Pathological Complete Response in a Patient With HER2-Negative Esophagogastric Junction Cancer Undergoing Conversion-Intent Surgery After Ramucirumab Plus Paclitaxel Following Nivolumab-Based Chemotherapy: A Case Report

Y. Yamasaki Kentaro Miyazaki Yuta Fujiwara Yukari Yamaguchi Keishi Nakamura K. Ishii K. Oyama

DOI PubMed Semantic Scholar